Key Events This Week
25 May: Flat quarterly performance reported with highest-ever net sales of ₹22.49 crores
25 May: Valuation reassessment highlights deteriorating financial metrics and elevated risk
26 May: Sharp price gain of 7.24% on heavy volume despite Sensex decline
27 May: Price correction of -3.96% amid mixed market sentiment
29 May: Week closes at Rs.21.88, up 1.34% for the week

Medico Intercontinental Ltd Faces Valuation Reassessment Amid Deteriorating Metrics
2026-05-25 08:01:18Medico Intercontinental Ltd, a micro-cap player in the Trading & Distributors sector, has seen a marked deterioration in its valuation parameters, prompting a downgrade to a Strong Sell rating. With its price-to-earnings ratio plunging into negative territory and price-to-book value remaining low, the stock’s price attractiveness has shifted from very expensive to risky, signalling caution for investors amid sustained underperformance against benchmark indices.
Read full news article
Medico Intercontinental Ltd Reports Flat Quarterly Performance Amidst Financial Struggles
2026-05-25 08:00:23Medico Intercontinental Ltd, a micro-cap player in the Trading & Distributors sector, has reported a flat financial performance for the quarter ended March 2026, signalling a pause in its previously negative trend. Despite achieving its highest quarterly net sales at ₹22.49 crores, the company continues to grapple with elevated debt levels and a deteriorating stock price, reflecting ongoing challenges in its operational and market positioning.
Read full news articleAre Medico Intercontinental Ltd latest results good or bad?
2026-05-23 19:24:22Medico Intercontinental Ltd's latest financial results for Q4 FY26 reveal a company grappling with significant operational challenges. The consolidated net profit for the quarter stood at a loss of ₹0.65 crores, marking a substantial decline compared to the previous year. Despite achieving net sales of ₹22.49 crores, which reflects a year-on-year growth of 6.29% and a quarter-on-quarter improvement of 13.30%, this revenue growth was insufficient to counteract severe margin compression and rising costs. The company's profit after tax (PAT) margin fell to -10.45%, a stark contrast to the positive margin of 5.43% reported in Q4 FY25. This indicates considerable operational distress, compounded by a significant increase in interest expenses, which surged to ₹1.85 crores from ₹0.30 crores year-on-year. The return on equity (ROE) has also plummeted to a mere 0.02%, highlighting the company's inability to generat...
Read full news articleMedico Intercontinental Falls 6.09%: Key Factors Behind the Steep Decline
2026-05-23 14:00:04
Key Events This Week
May 18: Stock opens at Rs.22.99, flat on the day
May 19: Sharp decline of 4.35% to Rs.21.99
May 21: Brief recovery with 4.10% gain to Rs.22.87
May 22: Stock hits 52-week low at Rs.20.81, closes at Rs.21.59 (-5.60%)

Medico Intercontinental Q4 FY26: Steep Losses Raise Serious Questions About Business Viability
2026-05-22 18:46:58Medico Intercontinental Limited, a micro-cap pharmaceutical trading company, reported a consolidated net loss of ₹0.65 crores for Q4 FY26, marking a dramatic reversal from the ₹1.17 crores profit recorded in the same quarter last year. The 155.56% year-on-year decline and 195.45% quarter-on-quarter deterioration signal deepening operational distress that has persisted throughout FY26. With a market capitalisation of just ₹23.00 crores and the stock trading at ₹21.59—down 5.6% on the day—investor confidence appears to be evaporating rapidly.
Read full news article
Medico Intercontinental Ltd Falls to 52-Week Low of Rs 20.81 as Sell-Off Deepens
2026-05-22 14:35:10For the fifth consecutive session, Medico Intercontinental Ltd closed lower, hitting a fresh 52-week low of Rs 20.81 on 22 May 2026, marking a steep decline of 48.32% over the past year amid persistent selling pressure.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
23-May-2026 | Source : BSENewspaper Publication
Announcement under Regulation 30 (LODR)-Meeting Updates
22-May-2026 | Source : BSEIntimation of Re-appointment of an Internal Auditors.
Results - Financial Year Ended March 31 2026.
22-May-2026 | Source : BSEResults for the quarter and financial year ended March 31 2026
Corporate Actions
No Upcoming Board Meetings
Medico Intercontinental Ltd has declared 1% dividend, ex-date: 23 Jun 23
No Splits history available
No Bonus history available
No Rights history available







